Skip to main content
. 2022 Feb 18;42(2):BSR20212119. doi: 10.1042/BSR20212119

Figure 4. High IGF2BP2 expression is associated with poor survival in OSCC patients.

Figure 4

(A) Overall survival of IGF2BP2high and IGF2BP2low patients analyzed with the dataset, GSE42743. (B) Overall survival of IGF2BP2high and IGF2BP2low OSCC patients analyzed with TCGA (n=311). (C) Overall survival of IGF2BP2high and IGF2BP2low OSCC patients analyzed with clinical samples (n=30).